QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

IONS

QT34Ionis Pharmaceuticals, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
74.12
-0.19-0.26%
OverviewShort InterestFilings
IONSQT34Ionis Pharmaceuticals, Inc.·NASDAQ
OverviewShort InterestFilings
74.12-0.26%

Latest SEC Filings

Form category
Filing Date ▾Report DateFormDescriptionFilingDocument
Jun 16, 2026Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 2026Jun 16, 20264Statement of changes in beneficial ownership
Jun 12, 2026Jun 12, 20268-KCurrent report
Jun 08, 2026Jun 08, 20263Initial statement of beneficial ownership
Jun 08, 2026Jun 08, 20268-KCurrent report
Jun 08, 2026Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 2026Jun 08, 20263Initial statement of beneficial ownership
Jun 08, 2026Jun 08, 20264Statement of changes in beneficial ownership
Jun 03, 2026Jun 03, 20264Statement of changes in beneficial ownership
Jun 01, 2026Jun 01, 2026144Notice of proposed sale of restricted securities
May 28, 2026May 28, 20268-KCurrent report
May 15, 2026May 15, 2026SC 13G/ASC 13G/A
May 15, 2026May 15, 20264Statement of changes in beneficial ownership
May 14, 2026May 14, 2026SC 13G/ASC 13G/A
May 13, 2026May 13, 2026144Notice of proposed sale of restricted securities
May 06, 2026May 06, 20264Statement of changes in beneficial ownership
May 05, 2026May 05, 20264Statement of changes in beneficial ownership
May 04, 2026May 04, 2026144Notice of proposed sale of restricted securities
Apr 30, 2026Apr 30, 2026SC 13GBeneficial ownership statement (passive)
Apr 30, 2026Apr 30, 20264Statement of changes in beneficial ownership
Apr 29, 2026Apr 29, 20268-KCurrent report
Apr 29, 2026Apr 29, 202610-QQuarterly report
Apr 28, 2026Apr 28, 2026144Notice of proposed sale of restricted securities
Apr 23, 2026Apr 23, 2026ARSARS
Apr 23, 2026Apr 23, 2026DEFA14AAdditional proxy soliciting materials
#1 / 25 of 500
Page
▼
/ 20